Case number 2020-1302
Mylan Laboratories Limited v. Sanofi Mature IP > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | MYLAN LABORATORIES LIMITED v. SANOFI MATURE IP [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 23, 2021 | 49 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [757908] [JCP] [Entered: 02/23/2021 10:05 AM] (0) |
| Jan 15, 2021 | 48 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [749674] [CAB] [Entered: 01/15/2021 09:54 AM] (0) |
| Jan 4, 2021 | 47 | Submitted after ORAL ARGUMENT to Panel: Newman, Circuit Judge; O'Malley, Circuit Judge and Wallach, Circuit Judge.Arguing counsel: Matthew R. Reed for Mylan Laboratories Limited and Daniel John Minion for Sanofi Mature IP.Oral Argument Audio available here. [746461] [JAB] [Entered: 01/04/2021 11:19 AM] (0) |
| Dec 22, 2020 | 46 | Amended Certificate of Interest for Appellant Mylan Laboratories Limited. Service: 12/22/2020 by email. [744917] [20-1302] [Steven Parmelee] [Entered: 12/22/2020 06:08 PM] (0) |
| Dec 21, 2020 | 45 | Clerk's letter to Appellant Mylan Laboratories Limited and Appellee Sanofi Mature IP regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [744272] [JAB] [Entered: 12/21/2020 12:42 PM] (0) |
| Dec 14, 2020 | 43 | Response to notice of oral argument from Appellant Mylan Laboratories Limited. Service: 12/14/2020 by email. [742628] [20-1302] [Steven Parmelee] [Entered: 12/14/2020 06:26 PM] (0) |
| Dec 14, 2020 | 44 | Response to notice of oral argument from Appellee Sanofi Mature IP. Service: 12/14/2020 by email. [742642] [20-1302] [Daniel Minion] [Entered: 12/14/2020 07:04 PM] (0) |
| Nov 20, 2020 | 42 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2101C. Case scheduled January 4, 2021. Response to Notice of Oral Argument due: 12/15/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [737236] [JAB] [Entered: 11/20/2020 10:52 AM] (0) |
| Jul 31, 2020 | 41 | 7 paper copies of the Confidential Appendix [27] received from Appellant Mylan Laboratories Limited and Appellee Sanofi Mature IP. [713051] [CJF] [Entered: 08/06/2020 01:42 PM] (0) |
| Jul 30, 2020 | 40 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Mylan Laboratories Limited and Appellee Sanofi Mature IP, paper copies of the Confidential Appendix [39], is not in compliance with the rules of this court (see attached). Compliant document due on 08/06/2020. Service as of this date by the Clerk of Court. [711196] [CJF] [Entered: 07/30/2020 09:06 AM] (0) |
| Jul 24, 2020 | 39 | 6 paper copies of the Confidential Appendix [27] received from Appellant Mylan Laboratories Limited and Appellee Sanofi Mature IP. This document is non-compliant. See Doc No.[40] [711190] [CJF] [Entered: 07/30/2020 08:55 AM] (0) |
| Jul 24, 2020 | 38 | 6 paper copies of the Reply Brief [26] received from Appellant Mylan Laboratories Limited. [711189] [CJF] [Entered: 07/30/2020 08:54 AM] (0) |
| Jul 24, 2020 | 36 | 6 paper copies of the Opening Brief [23] received from Appellant Mylan Laboratories Limited. [711177] [CJF] [Entered: 07/30/2020 08:19 AM] (0) |
| Jul 24, 2020 | 35 | Notice from Appellant Mylan Laboratories Limited regarding conflicts with oral argument. None. Service: 07/24/2020 by email. [709951] [20-1302] [Steven Parmelee] [Entered: 07/24/2020 12:34 PM] (0) |
| Jul 24, 2020 | 34 | Notice from Appellee Sanofi Mature IP regarding conflicts with oral argument. None. Service: 07/24/2020 by email. [709915] [20-1302] [Daniel Minion] [Entered: 07/24/2020 11:34 AM] (0) |
| Jul 21, 2020 | 37 | 6 paper copies of the Opening Response Brief [25] received from Appellee Sanofi Mature IP. [711186] [CJF] [Entered: 07/30/2020 08:50 AM] (0) |
| Jul 17, 2020 | 33 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before July 31, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [708300] [LMN] [Entered: 07/17/2020 02:51 PM] (0) |
| Jul 17, 2020 | 32 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [708299] [LMN] [Entered: 07/17/2020 02:46 PM] (1) |
| Jun 5, 2020 | 31 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellant Mylan Laboratories Limited. Service: 06/05/2020 by email. [699649] [20-1302] [Steven Parmelee] [Entered: 06/05/2020 03:37 PM] (5) |
| Jun 5, 2020 | 30 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellee Sanofi Mature IP. Service: 06/05/2020 by email. [699633] [20-1302] [Daniel Minion] [Entered: 06/05/2020 02:47 PM] (5) |
| Jun 5, 2020 | 29 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Mylan Laboratories Limited and Appellee Sanofi Mature IP. Service: 06/05/2020 by email. [699604] [20-1302] [Steven Parmelee] [Entered: 06/05/2020 02:00 PM] (6) |
| Jun 5, 2020 | 28 | MODIFIED ENTRY: APPENDIX FILED for Mylan Laboratories Limited and Sanofi Mature IP. Number of Pages: 715. Service: 06/05/2020 by email. [699601] --[Edited 07/17/2020 by LMN - compliance review complete] [Steven Parmelee] [Entered: 06/05/2020 01:58 PM] (715) |
| Jun 5, 2020 | 27 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED for Mylan Laboratories Limited and Sanofi Mature IP. Number of Pages: 723. Service: 06/05/2020 by email. [699596]--[Edited 07/17/2020 by LMN - compliance review complete] [Steven Parmelee] [Entered: 06/05/2020 01:53 PM] (0) |
| May 29, 2020 | 26 | MODIFIED ENTRY: REPLY BRIEF FILED for Mylan Laboratories Limited. Number of Pages: 29. Service: 05/29/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [698023]--[Edited 06/01/2020 by MJL - compliance review complete] [Steven Parmelee] [Entered: 05/29/2020 07:39 PM] (40) |
| May 8, 2020 | 25 | MODIFIED ENTRY: BRIEF FILED for Appellee Sanofi Mature IP. Number of Pages: 68. Service: 05/08/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [693344] --[Edited 05/19/2020 by LMN - compliance review complete] [Daniel Minion] [Entered: 05/08/2020 08:07 PM] (68) |
| May 7, 2020 | 24 | Entry of appearance for Michael S. Scerbo as of counsel for Appellee Sanofi Mature IP. Service: 05/07/2020 by email. [692845] [20-1302] [Daniel Minion] [Entered: 05/07/2020 01:50 PM] (2) |
| Apr 10, 2020 | 23 | MODIFIED ENTRY: BRIEF FILED for Mylan Laboratories Limited. Number of Pages: 49. Service: 04/10/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [686163]--[Edited 04/13/2020 by MJL - compliance review complete] [Michael Rosato] [Entered: 04/10/2020 08:12 PM] (117) |
| Apr 10, 2020 | 22 | Entry of appearance for G. Edward Powell III as of counsel for Appellant Mylan Laboratories Limited. Service: 04/10/2020 by email. [686109] [20-1302] [George Powell] [Entered: 04/10/2020 04:07 PM] (2) |
| Feb 10, 2020 | 21 | Certified list received. Service: 02/10/2020 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [669894] [LMN] [Entered: 02/10/2020 03:56 PM] (39) |
| Jan 30, 2020 | 20 | ORDER filed denying [7] motion filed by Aventis Pharma S.A. A copy of this order shall be transmitted to the merits panel assigned to this case. Service as of this date by the Clerk of Court. [667240] [NL] [Entered: 01/30/2020 11:37 AM] (2) |
| Jan 16, 2020 | 19 | REPLY of Appellee Sanofi Mature IP to response [16]. Service: 01/16/2020 by email. [664011] [20-1302] [Daniel Minion] [Entered: 01/16/2020 07:34 PM] (15) |
| Jan 14, 2020 | 16 | RESPONSE of Appellant Mylan Laboratories Limited to the motion to expedite briefing [7] filed by Appellee Aventis Pharma S.A., motion to expedite hearing [7] filed by Appellee Aventis Pharma S.A.. Service: 01/14/2020 by email. [663010] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:40 PM] (17) |
| Jan 14, 2020 | 18 | Docketing Statement for the Appellee Sanofi Mature IP. Service: 01/14/2020 by email. [663016] [20-1302] [Daniel Minion] [Entered: 01/14/2020 06:59 PM] (3) |
| Jan 14, 2020 | 17 | Certificate of Interest for Appellee Sanofi Mature IP. Service: 01/14/2020 by email. [663012] [20-1302] [Daniel Minion] [Entered: 01/14/2020 06:55 PM] (3) |
| Jan 14, 2020 | 15 | Docketing Statement for the Appellant Mylan Laboratories Limited. Service: 01/14/2020 by email. [663008] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:37 PM] (5) |
| Jan 14, 2020 | 14 | Certificate of Interest for Appellant Mylan Laboratories Limited. Service: 01/14/2020 by email. [663007] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:35 PM] (3) |
| Jan 14, 2020 | 13 | Entry of appearance for Jad A. Mills as of counsel for Appellant Mylan Laboratories Limited. Service: 01/14/2020 by email. [663006] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:34 PM] (2) |
| Jan 14, 2020 | 12 | Entry of appearance for Wendy L. Devine as of counsel for Appellant Mylan Laboratories Limited. Service: 01/14/2020 by email. [663005] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:33 PM] (2) |
| Jan 14, 2020 | 11 | Entry of appearance for Matthew R. Reed as of counsel for Appellant Mylan Laboratories Limited. Service: 01/14/2020 by email. [663004] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:31 PM] (2) |
| Jan 14, 2020 | 10 | Entry of appearance for Michael T. Rosato as of counsel for Appellant Mylan Laboratories Limited. Service: 01/14/2020 by email. [663003] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:30 PM] (2) |
| Jan 14, 2020 | 9 | Entry of appearance for Steven W. Parmelee as principal counsel for Appellant Mylan Laboratories Limited. Service: 01/14/2020 by email. [663002] [20-1302] [Steven Parmelee] [Entered: 01/14/2020 06:28 PM] (2) |
| Jan 9, 2020 | 8 | ORDER granting motion to substitute [6] filed by Appellee. The revised official caption and short caption are reflected in this order. Any opposition to the motion to expedite [7] shall be filed no later than January 14, 2020. Any reply in support of the motion [7] is due no later than January 17, 2020. Service as of this date by the Clerk of Court. [661933] [LMS] [Entered: 01/09/2020 03:06 PM] (2) |
| Jan 8, 2020 | 7 | MOTION of Appellee Aventis Pharma S.A. to expedite briefing schedule, to expedite hearing [Consent: opposed]. Service: 01/08/2020 by email. [661614] [20-1302] [Daniel Minion] [Entered: 01/08/2020 05:36 PM] (16) |
| Jan 8, 2020 | 6 | MOTION of Appellee Aventis Pharma S.A. to substitute party [Consent: unopposed]. Service: 01/08/2020 by email. [661612] [20-1302] [Daniel Minion] [Entered: 01/08/2020 05:33 PM] (16) |
| Jan 8, 2020 | 5 | Entry of appearance for Katherine E. Adams as of counsel for Appellee Aventis Pharma S.A.. Service: 01/08/2020 by email. [661610] [20-1302] [Daniel Minion] [Entered: 01/08/2020 05:29 PM] (2) |
| Jan 8, 2020 | 4 | Entry of appearance for Whitney L. Meier as of counsel for Appellee Aventis Pharma S.A.. Service: 01/08/2020 by email. [661608] [20-1302] [Daniel Minion] [Entered: 01/08/2020 05:28 PM] (2) |
| Jan 8, 2020 | 3 | Entry of appearance for William E. Solander as of counsel for Appellee Aventis Pharma S.A.. Service: 01/08/2020 by email. [661607] [20-1302] [Daniel Minion] [Entered: 01/08/2020 05:24 PM] (2) |
| Jan 8, 2020 | 2 | Entry of appearance for Daniel J. Minion as principal counsel for Appellee Aventis Pharma S.A.. Service: 01/08/2020 by email. [661606] [20-1302] [Daniel Minion] [Entered: 01/08/2020 05:23 PM] (2) |
| Dec 31, 2019 | 1 | Appeal docketed. Received: 12/23/2019. [659702] Entry of Appearance due 01/14/2020. Certificate of Interest is due on 01/14/2020. Docketing Statement due 01/14/2020. Certified List due on 02/10/2020. [TAM] [Entered: 12/31/2019 09:27 AM] (41) |
